{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:20:31Z","timestamp":1790508031386,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier","isbn-type":[{"value":"9780323901642","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.pbr.2022.01.015","type":"book-chapter","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T08:11:09Z","timestamp":1643962269000},"page":"195-226","source":"Crossref","is-referenced-by-count":13,"title":["Genetics of cognitive dysfunction in Parkinson's disease"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pbr.2022.01.015_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.14802\/jmd.19080","article-title":"Long-term outcomes of genetic Parkinson's disease","volume":"13","author":"Aasly","year":"2020","journal-title":"JMD"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/13803390903521018","article-title":"Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease","volume":"32","author":"Alcalay","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0020","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","article-title":"Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study","volume":"78","author":"Alcalay","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaneurol.2013.4498","article-title":"Cognitive and motor function in long-duration PARKIN-associated parkinson disease","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","article-title":"Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes","volume":"71","author":"Alcalay","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0035","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parkreldis.2014.09.033","article-title":"Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease","volume":"21","author":"Alcalay","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2018.01.012","article-title":"Alpha galactosidase a activity in Parkinson's disease","volume":"112","author":"Alcalay","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0050","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/mds.25535","article-title":"Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation","volume":"28","author":"Angeli","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"Anheim","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7800","article-title":"Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease: a systematic review and meta-analysis","volume":"2","author":"Artusi","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jns.2017.08.3259","article-title":"PITX3 genotype and risk of dementia in Parkinson's disease: a population-based study","volume":"381","author":"B\u00e4ckstr\u00f6m","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/1073858417748875","article-title":"Glucocerebrosidase and Parkinson disease: molecular, clinical, and therapeutic implications","volume":"24","author":"Balestrino","year":"2018","journal-title":"Neuroscientist"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104782","article-title":"Genetics of Parkinson's disease: an introspection of its journey towards precision medicine","volume":"137","author":"Bandres-Ciga","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.parkreldis.2010.09.003","article-title":"LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort","volume":"16","author":"Belarbi","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2011.10.009","article-title":"Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease","volume":"18","author":"Ben Sassi","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neurobiolaging.2008.03.008","article-title":"PITX3 polymorphism is associated with early onset Parkinson's disease","volume":"31","author":"Bergman","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FPC.0b013e32835693f7","article-title":"Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease","volume":"22","author":"Bialecka","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/brain\/awz350","article-title":"Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia","volume":"143","author":"Blauwendraat","year":"2020","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0105","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fneur.2018.01021","article-title":"A meta-analysis of \u03b1-synuclein multiplication in familial parkinsonism","volume":"9","author":"Book","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0110","first-page":"2412486","article-title":"LRRK2 G2019S mutation: prevalence and clinical features in moroccans with Parkinson's disease","volume":"2017","author":"Bouhouche","year":"2017","journal-title":"Parkinsons Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0115","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.1917914117","article-title":"The \u03b1-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure","volume":"117","author":"Boyer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/hmg\/dds475","article-title":"The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function","volume":"22","author":"Brady","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnagi.2017.00198","article-title":"Variants in SNCA gene are associated with Parkinson's disease risk and cognitive symptoms in a Brazilian sample","volume":"9","author":"Camp\u00ealo","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0135","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/ijms22031045","article-title":"Genetic and environmental factors influence the pleomorphy of LRRK2 parkinsonism","volume":"22","author":"Chittoor-Vinod","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA-associated Parkinson's disease: The mutation matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0145","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mds.20131","article-title":"Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations","volume":"19","author":"Clark","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fneur.2018.00213","article-title":"The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson's disease","volume":"9","author":"Corrado","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105056","article-title":"VPS35 and the mitochondria: connecting the dots in Parkinson's disease pathophysiology","volume":"145","author":"Cutillo","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0160","first-page":"4318416","article-title":"Genetic variants in SNCA and the risk of sporadic Parkinson's disease and clinical outcomes: a review","volume":"2017","author":"das Chagas Camp\u00ealo","year":"2017","journal-title":"Parkinsons Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0165","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0170","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","article-title":"APOE \u025b4 is associated with severity of Lewy body pathology independent of Alzheimer pathology","volume":"91","author":"Dickson","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mds.21319","article-title":"Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations","volume":"22","author":"Ephraty","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.parkreldis.2006.12.001","article-title":"Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia","volume":"13","author":"Farrer","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","article-title":"A large study reveals no association between APOE and Parkinson's disease","volume":"46","author":"Federoff","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0195","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.20118","article-title":"Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism","volume":"19","author":"Foltynie","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0200","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neurobiolaging.2007.08.014","article-title":"The transcription factor PITX3 is associated with sporadic Parkinson's disease","volume":"30","author":"Fuchs","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0205","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on Parkinson disease","volume":"84","author":"Gan-Or","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0210","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/acn3.228","article-title":"GBA mutations are associated with rapid eye movement sleep behavior disorder","volume":"2","author":"Gan-Or","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11910-018-0860-4","article-title":"GBA-associated Parkinson's disease and other Synucleinopathies","volume":"18","author":"Gan-Or","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0220","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/mds.27803","article-title":"Classification of GBA variants and their effects in synucleinopathies","volume":"34","author":"Gan-Or","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0235","first-page":"102","article-title":"A manual of diseases of the nervous system","volume":"49","author":"Gowers","year":"1892","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0240","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/mds.28197","article-title":"The Parkinson's disease genome-wide association study locus browser","volume":"35","author":"Grenn","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0245","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ana.24664","article-title":"\u03b1-Synuclein genetic variability: a biomarker for dementia in Parkinson disease","volume":"79","author":"Guella","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0250","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/mds.23693","article-title":"Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease","volume":"26","author":"Guo","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0255","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.3390\/ijms21197332","article-title":"Genetic risk profiling in Parkinson's disease and utilizing genetics to gain insight into disease-related biological pathways","volume":"21","author":"Hall","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0260","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0265","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0270","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/WNL.0000000000000675","article-title":"LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance","volume":"83","author":"Hentati","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0275","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.21059","article-title":"Phenotypic spectrum of PINK1-associated parkinsonism in 15 mutation carriers from 1 family","volume":"22","author":"Hiller","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0280","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jocn.2016.10.013","article-title":"Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease","volume":"36","author":"Hong","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0285","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/mds.23319","article-title":"Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease","volume":"25","author":"Hoogland","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archneur.63.2.189","article-title":"Apolipoprotein E and dementia in Parkinson disease: a meta-analysis","volume":"63","author":"Huang","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0295","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneurol.2008.555","article-title":"\u03b1-Synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms","volume":"66","author":"Ib\u00e1\u00f1ez","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0300","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12883-017-0978-z","article-title":"Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels","volume":"17","author":"Ibanez","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2020.03.017","article-title":"Parkinson's disease polygenic risk score is not associated with impulse control disorders: a longitudinal study","volume":"75","author":"Ihle","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0310","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/mds.27845","article-title":"Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts","volume":"34","author":"Iwaki","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0315","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0320","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","article-title":"The many faces of alpha-synuclein mutations","volume":"28","author":"Kasten","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0325","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.irn.2017.05.030","article-title":"Chapter six - nonmotor signs in genetic forms of Parkinson's disease","author":"Kasten","year":"2017"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0330","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.27352","article-title":"Genotype-phenotype relations for the Parkinson's disease genes parkin, PINK1, DJ1: MDSGene systematic review","volume":"33","author":"Kasten","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0335","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/awg142","article-title":"Parkin disease: a phenotypic study of a large case series","volume":"126","author":"Khan","year":"2003","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0037-1601567","article-title":"Genetic forms of Parkinson's disease","volume":"37","author":"Kim","year":"2017","journal-title":"Semin. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2020.03.003","article-title":"Comprehensive assessment of PINK1 variants in Parkinson's disease","volume":"91","author":"Krohn","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0350","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000492","article-title":"Genetic risk scores and hallucinations in patients with Parkinson disease","volume":"6","author":"Kusters","year":"2020","journal-title":"Neurol Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0355","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27059","article-title":"Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry","volume":"32","author":"Lee","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0360","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/mds.27427","article-title":"Polygenic load: earlier disease onset but similar longitudinal progression in Parkinson's disease","volume":"33","author":"Lerche","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0365","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in north African Arabs","volume":"354","author":"Lesage","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0370","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fneur.2020.00682","article-title":"Genetic and phenotypic basis of autosomal dominant Parkinson's disease in a large multi-center cohort","volume":"11","author":"Lesage","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0375","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.25787","article-title":"Characterization of recessive Parkinson disease in a large multicenter study","volume":"88","author":"Lesage","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000327098.86861.d4","article-title":"A multidisciplinary study of patients with early-onset PD with and without parkin mutations","volume":"72","author":"Lohmann","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10048-008-0140-6","article-title":"The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population","volume":"9","author":"Lu","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0390","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","article-title":"The genetic landscape of Parkinson's disease","volume":"174","author":"Lunati","year":"2018","journal-title":"Rev. Neurol. (Paris)."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0395","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3233\/JPD-171172","article-title":"GBA-associated Parkinson's disease: progression in a deep brain stimulation cohort","volume":"7","author":"Lythe","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2020.04.002","article-title":"Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations","volume":"76","author":"Mangone","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0405","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.635958","article-title":"Cognitive functioning of glucocerebrosidase (GBA) non-manifesting carriers","volume":"12","author":"Moran","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0415","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson's disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0420","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0425","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0430","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/mds.27768","article-title":"SNCA Rep1 promoter variability influences cognition in Parkinson's disease","volume":"34","author":"Ng","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0435","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.07.023","article-title":"Neuropathological findings in PINK1-associated Parkinson's disease","volume":"78","author":"Nyb\u00f8","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0440","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0445","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.parkreldis.2019.08.005","article-title":"Expanding the canvas of PRKN mutations in familial and early-onset Parkinson disease","volume":"66","author":"Pandey","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0450","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in parkinson's disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0455","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"APOE, MAPT, and COMT and Parkinson's disease susceptibility and cognitive symptom progression","volume":"6","author":"Paul","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0460","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2017.4206","article-title":"Association of polygenic risk score with cognitive decline and motor progression in Parkinson disease","volume":"75","author":"Paul","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0465","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/mds.28195","article-title":"GBA-related Parkinson's disease: dissection of genotype\u2013phenotype correlates in a large italian cohort","volume":"35","author":"Petrucci","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0470","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ene.14115","article-title":"Cognitive and psychiatric symptoms in genetically determined Parkinson's disease: a systematic review","volume":"27","author":"Piredda","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0475","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: the aging, demographics, and memory study","volume":"29","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0480","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0485","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.25994","article-title":"Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families","volume":"29","author":"Ricciardi","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0490","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson's disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0495","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0500","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.parkreldis.2010.06.015","article-title":"Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study","volume":"16","author":"Ryu","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0505","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0510","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamaneurol.2017.4019","article-title":"Progression in the LRRK2-asssociated Parkinson disease population","volume":"75","author":"Saunders-Pullman","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","article-title":"Glucocerebrosidase and Parkinson disease: recent advances","volume":"66","author":"Schapira","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0520","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0525","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28521","article-title":"Genetic variations and neuropathologic features of patients with PRKN mutations","author":"Seike","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0535","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/mds.23746","article-title":"Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease","volume":"26","author":"Shanker","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0540","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmedgenet-2012-101155","article-title":"A multi-Centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants","volume":"49","author":"Sharma","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0545","series-title":"Clinical Neuropsychology and Cognitive Neurology of Parkinson Disease and Other Movement Disorders","first-page":"179","article-title":"Genetics and cognition in Parkinson's disease","author":"Sharp","year":"2015"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0550","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1523\/JNEUROSCI.1666-18.2018","article-title":"New Frontiers in Parkinson's disease: from genetics to the clinic","volume":"38","author":"Shihabuddin","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0555","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jamaneurol.2016.1593","article-title":"High frequency of GBA gene mutations in dementia with Lewy bodies among Ashkenazi jews","volume":"73","author":"Shiner","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnagi.2019.00013","article-title":"A comprehensive analysis of population differences in LRRK2 variant distribution in Parkinson's disease","volume":"11","author":"Shu","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0565","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0570","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/mds.21114","article-title":"Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques","volume":"21","author":"Sim\u00f3n-S\u00e1nchez","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0575","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0580","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2015.02.019","article-title":"Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene","volume":"21","author":"Somme","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0585","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.26161","article-title":"Cognitive profile of LRRK2-related Parkinson's disease","volume":"30","author":"Srivatsal","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0590","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-014-1179-1","article-title":"VPS35 Parkinson's disease phenotype resembles the sporadic disease","volume":"121","author":"Struhal","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0595","article-title":"Dementia in long-term Parkinson's disease patients: a multicentre retrospective study. NPJ","volume":"6","author":"Szeto Jennifer","year":"2020","journal-title":"Parkinson's Dis."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0600","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/brain\/aww080","article-title":"DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology","volume":"139","author":"Taipa","year":"2016","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0605","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fgene.2019.00644","article-title":"Meta-analysis of the effects of the catechol-O-methyltransferase Val158\/108Met polymorphism on Parkinson's disease susceptibility and cognitive dysfunction","volume":"10","author":"Tang","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.12.014","article-title":"A \"dose\" effect of mutations in the GBA gene on Parkinson's disease phenotype","volume":"36","author":"Thaler","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0615","series-title":"Chapter 28 - The genetics of dementia with Lewy bodies","first-page":"431","author":"Tolea","year":"2018"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0620","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/mds.27527","article-title":"Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review","volume":"33","author":"Trinh","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0625","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.25486","article-title":"TMEM106B effect on cognition in Parkinson disease and frontotemporal dementia","volume":"85","author":"Tropea","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0630","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03f54 increases risk for dementia in pure Synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0635","doi-asserted-by":"crossref","first-page":"631145","DOI":"10.3389\/fneur.2021.631145","article-title":"APOE and MAPT are associated with dementia in neuropathologically confirmed Parkinson's disease","volume":"12","author":"Tunold","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0640","first-page":"57","article-title":"Un cas de maladie de Gaucher de l'adulte avec syndrome de Raynaud, pigmentation, et rigidite du type extra-pyramidal aux membrs inferieurs","volume":"45","author":"Van Bogaert","year":"1939","journal-title":"Ann. Med."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0645","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.536","article-title":"Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions","volume":"42","author":"Van Deerlin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0650","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilari\u00f1o-G\u00fcell","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0655","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2013.08.012","article-title":"Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals","volume":"35","author":"Wang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0660","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2017.07.003","article-title":"Influence of L-dopa on subtle motor signs in heterozygous parkin- and PINK1 mutation carriers","volume":"42","author":"Weissbach","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0665","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/brain\/awm313","article-title":"Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype","volume":"131","author":"Williams-Gray","year":"2008","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0670","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2022.01.015_bb0675","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neures.2020.04.007","article-title":"PINK1 and parkin: The odd couple","volume":"159","author":"Yoboue","year":"2020","journal-title":"Neurosci. Res."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00438","article-title":"Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson's disease","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/bs.pbr.2022.01.015_bb0685","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/621873","article-title":"Cognitive impairments in LRRK2-related Parkinson's disease: a study in Chinese individuals","volume":"2015","author":"Zheng","year":"2015","journal-title":"Behav. Neurol."}],"container-title":["Progress in Brain Research","Cognition in Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612322000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612322000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:09:26Z","timestamp":1753448966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612322000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323901642"],"references-count":136,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2022.01.015","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}